Genetic correlations between schizophrenia and CVD close to zero, but schizophrenia liability may increase heart failure risk
MONDAY, Nov. 29, 2021 (HealthDay News) — Evidence suggests that liability to schizophrenia causally increases the risk of heart failure and early repolarization pattern, but a shared genetic etiology seems not to underlie the association between schizophrenia and cardiovascular disease (CVD), according to a study published online Nov. 3 in the Schizophrenia Bulletin.
Rada R. Veeneman, from the University of Amsterdam, and colleagues obtained summary data of genome-wide association studies of schizophrenia, heart failure, coronary artery disease, systolic and diastolic blood pressure, heart rate variability, QT interval, and early repolarization and dilated cardiomyopathy electrocardiogram patterns. Genetic correlations were computed and causality was assessed in bidirectional Mendelian randomization (MR).
The researchers found that the genetic correlations were close to zero for schizophrenia and CVD (−0.02 to 0.04). Evidence suggested that liability to schizophrenia causally increased the risk of heart failure. The correlation remained consistent with multivariable MR. Evidence was also seen indicating that liability to schizophrenia increased early repolarization pattern, which was mediated mainly by body mass index and lipids. In addition, evidence was observed that liability to schizophrenia increased heart rate variability; the direction of effect was in contrast to clinical studies.
“The lack of evidence for genetic correlation between schizophrenia and CVD is striking, given consistent phenotypic correlations and the fact that a considerable amount of the risk variants for schizophrenia are located in genes relevant for cardiological functioning,” the authors write.
2011 to 2021 Saw Heart Failure-Related Hospitalization Rise in CKD
Machine Learning Model IDs Heart Failure With Reduced Ejection Fraction Using Routine Lab Indicators
Brain Abnormalities Identified in Children at Risk for Schizophrenia
Systemic Physical Multimorbidity Higher With Schizophrenia-Spectrum, Bipolar Disorder
Ketogenic Diet Beneficial in Schizophrenia, Bipolar-1 Disorders
Brain Lithium Concentrations Mirror Serum Concentrations in Bipolar Disorder
Lower Dementia Risk Seen With SGLT2is in Seniors 65+ With Mood, Psychotic Disorders
Social Determinants of Health Tied to Neurobiological Abnormalities in Schizophrenia